Stock screenerAll disclosures → EDGAR →
NXL
Conviction 67HealthcareScan · Tue, Sep 8, 2026Hanging man
NXL$4.91-2.96%
ResistanceSupportVol 14Vol MA14 172.42K
Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8
Price4.91
Change-2.96%
Gap-2.47%
Rel volume0.06×
Avg volume140.29K
Avg $ vol77.39K
SMA 202.00
SMA 501.04
SMA 2000.6709
Price vs 50+371.91%
Price vs 200+631.89%
MA stackbullish
50/200 crossgolden · 4d
Supertrendup · 4.66
RSI (14)70
MACD hist0.48
MACD crossbull · 5d
Stoch %K / %D63 / 65
ADX (14)42
+DI / −DI60 / 17
RSI divergence—
MACD divergenceBullish
ATR %+12.46%
ADR %8.67%
52w high7.23
52w low0.2500
From 52w high-32.09%
Above 52w low+1864.00%
New 52w highNo
SqueezeOff
Bollinger width521.63%
%B0.78
Donchian pos62.78%
Donchian high7.69
Donchian low0.2201
AVWAP (52w high)6.08
vs AVWAP high-19.25%
AVWAP (52w low)0.7319
vs AVWAP low+570.85%
OBV trendDown
Chaikin MF (20)-0.06
Today vs 20d0.06×
Avg vol (14d)172.42K
Avg vol (20d)140.29K
Avg $ vol (20d)77.39K
Market cap108.2M
RS 3m (vs SPY)+861.78%
RS 6m (vs SPY)+1032.59%
RS line new highNo
Trend template5/8
Technical rank94.6
1 week-32.09%
1 month+1291.33%
3 months+879.06%
6 months+978.65%
1 year+487.25%
YTD+742.77%
P/E-13.16
P/B71.21
P/S358.69
P/FCF—
EPS-0.5000
Div yield—
ROE-541.14%
ROA-273.69%
Debt/Eq—
Current1.25
EV/EBITDA—
Gross margin79.65%
Net margin—
Rev growth78.78%
EPS growth-8.08%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value107.19M
Revenue12.16K
Net income-2.24M
Gross profit8.9K
Free cash flow—
IndustryElectromedical & Electrotherapeutic Apparatus
ExchangeNasdaq
Shares out20.58M
Employees8
ListedFri, Sep 16, 2022
Free float15.38M
Float %74.8%
Short interest342.21K
Days to cover3.0d
Short volume69.8%
Squeeze score39 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeB
Conviction67 / 100
Pattern quality—
Tech rank94.6 / 100
Group rank—
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmHanging man
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in NXL
No recent disclosed trades by Congress in NXL. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in NXL
No recent insider (Form 4) filings in NXL. Insiders must file within two business days of a trade.
SEC filings
EDGAR filings in NXL · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.